CO5180587A1 - Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes - Google Patents

Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes

Info

Publication number
CO5180587A1
CO5180587A1 CO00068859A CO00068859A CO5180587A1 CO 5180587 A1 CO5180587 A1 CO 5180587A1 CO 00068859 A CO00068859 A CO 00068859A CO 00068859 A CO00068859 A CO 00068859A CO 5180587 A1 CO5180587 A1 CO 5180587A1
Authority
CO
Colombia
Prior art keywords
dispersant
pharmaceutical composition
tensoactive
composition containing
orlistat
Prior art date
Application number
CO00068859A
Other languages
English (en)
Spanish (es)
Inventor
Smidt Passchier Christiaan De
Paul Hadvary
Hans Lengsfeld
Thomas Rades
Hans Steffen
Joseph Tardio
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238990&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5180587(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO5180587A1 publication Critical patent/CO5180587A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO00068859A 1999-09-13 2000-09-12 Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes CO5180587A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99118180 1999-09-13

Publications (1)

Publication Number Publication Date
CO5180587A1 true CO5180587A1 (es) 2002-07-30

Family

ID=8238990

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00068859A CO5180587A1 (es) 1999-09-13 2000-09-12 Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes

Country Status (38)

Country Link
US (3) US20030181512A1 (cs)
EP (1) EP1216025B1 (cs)
JP (1) JP4217016B2 (cs)
KR (1) KR100572434B1 (cs)
CN (1) CN1197551C (cs)
AR (1) AR025587A1 (cs)
AT (1) ATE333866T1 (cs)
AU (1) AU769415B2 (cs)
BR (2) BRPI0013939B1 (cs)
CA (1) CA2383916C (cs)
CO (1) CO5180587A1 (cs)
CY (1) CY1106180T1 (cs)
CZ (1) CZ301901B6 (cs)
DE (1) DE60029602T2 (cs)
DK (1) DK1216025T3 (cs)
EG (1) EG24117A (cs)
ES (1) ES2267563T3 (cs)
HR (1) HRP20020205B1 (cs)
HU (1) HU228858B1 (cs)
IL (1) IL148494A0 (cs)
JO (1) JO2386B1 (cs)
MA (1) MA26818A1 (cs)
ME (1) ME00674B (cs)
MX (1) MXPA02002034A (cs)
MY (1) MY130200A (cs)
NO (1) NO331906B1 (cs)
NZ (1) NZ517545A (cs)
PE (1) PE20010595A1 (cs)
PL (1) PL199870B1 (cs)
PT (1) PT1216025E (cs)
RS (1) RS50422B (cs)
RU (1) RU2239428C2 (cs)
SI (1) SI1216025T1 (cs)
TR (1) TR200200606T2 (cs)
TW (1) TWI243060B (cs)
UY (1) UY26338A1 (cs)
WO (1) WO2001019340A1 (cs)
ZA (1) ZA200201518B (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8969901A (en) 2000-07-28 2002-02-13 Hoffmann La Roche New pharmaceutical composition
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US6730319B2 (en) * 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
FI20045076L (fi) * 2004-03-15 2005-09-16 Bioferme Oy Funktionaalinen elintarvike
US8241664B2 (en) * 2005-04-15 2012-08-14 Clarus Therapeutics, Inc Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
KR100910000B1 (ko) * 2005-05-13 2009-07-29 씨제이제일제당 (주) 리파아제 저해제 함유 약학 조성물
WO2006132440A1 (ja) * 2005-06-09 2006-12-14 Takeda Pharmaceutical Company Limited 固形製剤
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
KR101252635B1 (ko) * 2006-04-20 2013-04-10 (주)아모레퍼시픽 리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제
TR200607613A2 (tr) * 2006-12-29 2008-07-21 NOBEL İLAÇ SAN.ve TiC.A.Ş. Lipaz inhibitörü içeren farmasötik formülasyonlar
EP1970051A1 (en) * 2007-03-14 2008-09-17 Merz Pharma GmbH & Co.KGaA Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
DE602007008567D1 (de) * 2007-09-12 2010-09-30 Mader S R L Pharmazeutische Zusammensetzungen zur oralen Verabreichung bei der Behandlung von Adipositas-Patienten
EP2044930A1 (en) * 2007-10-01 2009-04-08 Nestec S.A. Composition for controlling lipase catalyzed reactions
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
KR20100075260A (ko) * 2008-12-24 2010-07-02 주식회사종근당 리파아제 저해제의 부작용 개선을 위한 신규한 약제학적 조성물
BRPI0901602B8 (pt) 2009-04-03 2021-05-25 Ems S/A formulação farmacêuticas
RU2441654C2 (ru) * 2010-02-17 2012-02-10 Лабораториос Баго С.А. Фармацевтическая композиция с активностью против ожирения, включающая премикс чистого орлистата, и способ ее изготовления
ITRM20120331A1 (it) 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.
BR112017021995A2 (pt) * 2015-04-14 2018-07-10 Zim Laboratories Ltd formulação farmacêutica compreendendo drogas de baixa fusão e altamente lipofílicas e método de melhora da dissolução
CN106310287B (zh) * 2015-06-25 2019-03-19 山东省药学科学院 新利司他药用组合物及其制备方法
MY196635A (en) * 2018-06-22 2023-04-25 Sime Darby Plantation Intellectual Property Sdn Bhd Method For Reducing Formation of Free Fatty Acids in Plants
CN115105476B (zh) * 2021-03-23 2023-11-14 山东新时代药业有限公司 一种奥利司他冻干口服制剂及其制备工艺
CN114983938A (zh) * 2022-05-19 2022-09-02 广东嘉博制药有限公司 一种奥利司他口服复合乳液及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
SU1510148A1 (ru) * 1988-01-26 1995-04-30 Всесоюзный научно-исследовательский институт химии и технологии лекарственных средств Способ получения ингибитора липазы
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
IT1282673B1 (it) 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
EP1017366A4 (en) 1996-09-01 2006-03-22 Pharmos Corp SOLID COPARCIPITATES FOR IMPROVED BIOVERABILITY OF LIPOPHILIC SUBSTANCES
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
BR9807655A (pt) * 1997-02-05 2000-02-15 Hoffmann La Roche Uso de inibidores de lipase gastrintestinal.
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
CN1170534C (zh) 1998-08-14 2004-10-13 霍夫曼-拉罗奇有限公司 含有脂酶抑制剂的药物组合物
KR20010079636A (ko) 1998-08-14 2001-08-22 프리돌린 클라우스너, 롤란드 비. 보레르 라이페이즈 저해제 및 키토산을 포함하는 약학 조성물
US6368622B2 (en) * 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption

Also Published As

Publication number Publication date
BRPI0013939B1 (pt) 2017-07-18
DE60029602D1 (de) 2006-09-07
PT1216025E (pt) 2006-12-29
AU769415B2 (en) 2004-01-29
TWI243060B (en) 2005-11-11
MA26818A1 (fr) 2004-12-20
NO331906B1 (no) 2012-04-30
CZ20021276A3 (cs) 2003-04-16
SI1216025T1 (sl) 2006-12-31
HRP20020205A2 (en) 2004-04-30
MXPA02002034A (es) 2002-08-20
RU2239428C2 (ru) 2004-11-10
RS50422B (sr) 2009-12-31
JO2386B1 (en) 2007-06-17
AR025587A1 (es) 2002-12-04
CN1373656A (zh) 2002-10-09
KR20020063852A (ko) 2002-08-05
ATE333866T1 (de) 2006-08-15
HU228858B1 (en) 2013-06-28
US20040175420A1 (en) 2004-09-09
BR0013939A (pt) 2002-05-14
PL199870B1 (pl) 2008-11-28
US20030181512A1 (en) 2003-09-25
PL356174A1 (en) 2004-06-14
CA2383916C (en) 2009-01-20
HRP20020205B1 (hr) 2011-06-30
DE60029602T2 (de) 2007-07-26
TR200200606T2 (tr) 2002-07-22
DK1216025T3 (da) 2006-10-30
PE20010595A1 (es) 2001-05-26
YU17202A (sh) 2006-01-16
CZ301901B6 (cs) 2010-07-28
NO20021204L (no) 2002-03-12
JP2003509357A (ja) 2003-03-11
MEP90808A (en) 2011-12-20
JP4217016B2 (ja) 2009-01-28
CY1106180T1 (el) 2011-06-08
US8012494B2 (en) 2011-09-06
IL148494A0 (en) 2002-09-12
KR100572434B1 (ko) 2006-04-18
ZA200201518B (en) 2003-07-30
HUP0202737A2 (hu) 2003-01-28
EP1216025B1 (en) 2006-07-26
WO2001019340A1 (en) 2001-03-22
ME00674B (me) 2011-12-20
AU7286300A (en) 2001-04-17
NO20021204D0 (no) 2002-03-12
US20110275706A1 (en) 2011-11-10
NZ517545A (en) 2003-11-28
ES2267563T3 (es) 2007-03-16
EG24117A (en) 2008-07-06
CN1197551C (zh) 2005-04-20
MY130200A (en) 2007-06-29
HUP0202737A3 (en) 2005-01-28
CA2383916A1 (en) 2001-03-22
UY26338A1 (es) 2000-10-31
EP1216025A1 (en) 2002-06-26
HK1049966A1 (en) 2003-06-06

Similar Documents

Publication Publication Date Title
CO5180587A1 (es) Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes
BR0215405A (pt) Composições e processos de uso de collajolie
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
ES2114487B1 (es) Mezcla estabilizante sinergistica.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
BR0317715A (pt) Composições e processos de uso de collajolie
ES2178298T3 (es) Compuestos anti-inflamatorios.
ATE231393T1 (de) Flüssige zusammensetzung, hiv protease inhibitoren und c12-c18 fettsaure enthaltend
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
ES2196502T3 (es) Composicion y metodo para inhibir el desarrollo de microorganismos que incluye hipobromito sodico estabilizado e isotiazolonas.
HN2001000146A (es) Derivados de pirazol
GB9717905D0 (en) Lipid-containing compositions and uses thereof
ES2134924T3 (es) Acidos sulfonilalcanoilamino-hidroxietilamino-sulfamicos utiles como inhibidores de proteasas retrovirales.
SE9801494D0 (sv) Novel use
AR030662A1 (es) Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos
BR0003766A (pt) Misturas de tensoativos compreendendo ácido graxo n-alquilpolihidroxiamidas e ácido graxo amidoalcoxilatos
ES2153565T3 (es) Procedimiento y compuestos para la deteccion de analitos mediante medicion de la remanencia, y su utilizacion.
AR013411A1 (es) Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones.
ES2187184T3 (es) Fosfoepoxidos, procedimiento de fabricacion y aplicaciones.
ES2186989T3 (es) Cristales de maltitol de formas especificas, compuestos cristalinos que los contienen y procedimientos para su preparacion.
HN2000000056A (es) Nuevas formas cristalinas de un antibiotico macrolido
BG100248A (bg) Инхибитори на скваленсинтетаза
EE04750B1 (et) HIV-proteaasi inhibiitorite valmistamismeetod
BR0112600A (pt) Compostos calcilìticos

Legal Events

Date Code Title Description
FG Application granted